Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.680
-0.070 (-4.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.670
-0.010 (-0.60%)
After-hours: Apr 28, 2026, 7:56 PM EDT
BDMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 22.54 | 37.04 | 31.46 | 35.09 | 29.7 | Upgrade
|
| Revenue Growth (YoY) | -39.15% | 17.73% | -10.35% | 18.16% | 63.92% | Upgrade
|
| Cost of Revenue | 3.65 | 4.38 | 4.23 | 7.05 | 5.03 | Upgrade
|
| Gross Profit | 18.88 | 32.65 | 27.23 | 28.04 | 24.67 | Upgrade
|
| Selling, General & Admin | 24.38 | 11.16 | 11.09 | 10.55 | 8.64 | Upgrade
|
| Research & Development | 20.13 | 6.17 | 4.27 | 3.86 | 1.54 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.31 | Upgrade
|
| Operating Expenses | 44.51 | 17.34 | 15.37 | 14.41 | 10.07 | Upgrade
|
| Operating Income | -25.63 | 15.32 | 11.86 | 13.63 | 14.6 | Upgrade
|
| Interest Expense | -0.74 | -0.58 | -0.29 | -0.3 | -0.15 | Upgrade
|
| Interest & Investment Income | - | 0 | 0 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.65 | 0.78 | 1.18 | -0.98 | Upgrade
|
| EBT Excluding Unusual Items | -26.37 | 14.09 | 12.36 | 14.52 | 13.52 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.79 | Upgrade
|
| Pretax Income | -26.37 | 14.09 | 12.36 | 14.52 | 14.32 | Upgrade
|
| Income Tax Expense | 1.17 | 1.49 | 1.7 | 1.75 | 2.53 | Upgrade
|
| Earnings From Continuing Operations | -27.54 | 12.6 | 10.66 | 12.77 | 11.78 | Upgrade
|
| Minority Interest in Earnings | 0.26 | -0.14 | -0.11 | -0.21 | -0.1 | Upgrade
|
| Net Income | -27.28 | 12.45 | 10.55 | 12.57 | 11.68 | Upgrade
|
| Net Income to Common | -27.28 | 12.45 | 10.55 | 12.57 | 11.68 | Upgrade
|
| Net Income Growth | - | 18.09% | -16.09% | 7.60% | 64.54% | Upgrade
|
| Shares Outstanding (Basic) | 28 | 26 | 26 | 26 | 1,181 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 26 | 26 | 26 | 1,181 | Upgrade
|
| Shares Change (YoY) | 8.45% | 0.29% | - | -97.84% | - | Upgrade
|
| EPS (Basic) | -0.98 | 0.49 | 0.41 | 0.49 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.98 | 0.49 | 0.41 | 0.49 | 0.01 | Upgrade
|
| EPS Growth | - | 18.86% | -16.33% | 4853.49% | - | Upgrade
|
| Free Cash Flow | -1.39 | -9.17 | -3.66 | -5.42 | 5.92 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.36 | -0.14 | -0.21 | 0.01 | Upgrade
|
| Gross Margin | 83.79% | 88.17% | 86.56% | 79.90% | 83.08% | Upgrade
|
| Operating Margin | -113.73% | 41.35% | 37.71% | 38.85% | 49.16% | Upgrade
|
| Profit Margin | -121.04% | 33.62% | 33.52% | 35.82% | 39.33% | Upgrade
|
| Free Cash Flow Margin | -6.15% | -24.75% | -11.63% | -15.46% | 19.95% | Upgrade
|
| EBITDA | -24.53 | 16.45 | 12.88 | 14.55 | 15.42 | Upgrade
|
| EBITDA Margin | -108.83% | 44.43% | 40.93% | 41.46% | 51.91% | Upgrade
|
| D&A For EBITDA | 1.1 | 1.14 | 1.01 | 0.92 | 0.82 | Upgrade
|
| EBIT | -25.63 | 15.32 | 11.86 | 13.63 | 14.6 | Upgrade
|
| EBIT Margin | -113.73% | 41.35% | 37.71% | 38.85% | 49.16% | Upgrade
|
| Effective Tax Rate | - | 10.57% | 13.76% | 12.03% | 17.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.